Literature DB >> 17306775

3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.

José Manuel Trigo1, Thibault Renoir, Laurence Lanfumey, Michel Hamon, Klaus-Peter Lesch, Patricia Robledo, Rafael Maldonado.   

Abstract

BACKGROUND: The neurobiological mechanism underlying the reinforcing effects of 3,4-methylenedioxymethamphetamine (MDMA) remains unclear. The aim of the present study was to determine the contribution of the serotonin transporter (SERT) in MDMA self-administration behavior by using knockout (KO) mice deficient in SERT.
METHODS: Knockout mice and wild-type (WT) littermates were trained to acquire intravenous self-administration of MDMA (0, .03, .06, .125, and .25 mg/kg/infusion) on a fixed ratio 1 (FR1) schedule of reinforcement. Additional groups of mice were trained to obtain food and water to rule out operant responding impairments. Microdialysis studies were performed to evaluate dopamine (DA) and serotonin (5-HT) extracellular levels in the nucleus accumbens (NAC) and prefrontal cortex (PFC), respectively, after acute MDMA (10 mg/kg).
RESULTS: None of the MDMA doses tested maintained intravenous self-administration in KO animals, whereas WT mice acquired responding for MDMA. Acquisition of operant responding for food and water was delayed in KO mice, but no differences between genotypes were observed on the last day of training. MDMA increased DA extracellular levels to a similar extent in the NAC of WT and KO mice. Conversely, extracellular concentrations of 5-HT in the PFC were increased following MDMA only in WT mice.
CONCLUSIONS: These findings provide evidence for the specific involvement of SERT in MDMA reinforcing properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306775     DOI: 10.1016/j.biopsych.2006.11.005

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  34 in total

1.  A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats.

Authors:  A C Oakly; B W Brox; S Schenk; B A Ellenbroek
Journal:  Mol Psychiatry       Date:  2013-05-28       Impact factor: 15.992

2.  Boron-Doped Diamond Microelectrodes Reveal Reduced Serotonin Uptake Rates in Lymphocytes from Adult Rhesus Monkeys Carrying the Short Allele of the 5-HTTLPR.

Authors:  Yogesh S Singh; Lauren E Sawarynski; Heather M Michael; Robert E Ferrell; Michael A Murphey-Corb; Greg M Swain; Bhavik A Patel; Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2010-01-20       Impact factor: 4.418

3.  Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Authors:  Stephen J Kish; Jason Lerch; Yoshiaki Furukawa; Junchao Tong; Tina McCluskey; Diana Wilkins; Sylvain Houle; Jeffrey Meyer; Emanuela Mundo; Alan A Wilson; Pablo M Rusjan; Jean A Saint-Cyr; Mark Guttman; D Louis Collins; Colin Shapiro; Jerry J Warsh; Isabelle Boileau
Journal:  Brain       Date:  2010-05-17       Impact factor: 13.501

4.  MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro.

Authors:  Luise Liebig; Andreas von Ameln-Mayerhofer; Harald Hentschke
Journal:  Exp Brain Res       Date:  2014-09-19       Impact factor: 1.972

5.  Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice.

Authors:  Morgane Thomsen; F Scott Hall; George R Uhl; S Barak Caine
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

Review 6.  A pharmacological analysis of mice with a targeted disruption of the serotonin transporter.

Authors:  Meredith A Fox; Anne M Andrews; Jens R Wendland; Klaus-Peter Lesch; Andrew Holmes; Dennis L Murphy
Journal:  Psychopharmacology (Berl)       Date:  2007-08-22       Impact factor: 4.530

Review 7.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

8.  Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.

Authors:  María Juliana Orejarena; Fernando Berrendero; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2009-06-04       Impact factor: 4.530

Review 9.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

10.  cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake.

Authors:  Jennifer A Steiner; Ana Marin D Carneiro; Jane Wright; Heinrich J G Matthies; Harish C Prasad; Christian K Nicki; Wolfgang R Dostmann; Carrie C Buchanan; Jackie D Corbin; Sharron H Francis; Randy D Blakely
Journal:  Mol Brain       Date:  2009-08-05       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.